Fundraising FoxEnara Bio
7 known investors
Find your way into Enara Bio
Sign up to find every way you can get introduced to Enara Bio
- Your email: who you already know at Enara Bio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Enara Bio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Enara Bio discovers and validates Dark Antigens from non-coding genomic regions to identify novel cancer targets, and develops first-in-class bispecific T-cell engagers against these targets through its EnTiCE platform. The company serves cancer patients and collaborates with pharmaceutical companies and academic research institutions.
Founders & leadership
Investors · 7
How we know: RA Capital's portfolio page · the company's own site · Not right? Tell us
How we know: the company's own site · SV Health Investors's portfolio page · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: Dementia Discovery Fund's portfolio page · Not right? Tell us
How we know: M Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Pfizer Venture Investments's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Enara Bio do?
- Enara Bio discovers and validates Dark Antigens from non-coding genomic regions to identify novel cancer targets, and develops first-in-class bispecific T-cell engagers against these targets through its EnTiCE platform. The company serves cancer patients and collaborates with pharmaceutical companies and academic research institutions.
- Who founded Enara Bio?
- Enara Bio was founded by George Kassiotis, Drew Pardoll, Houman Ashrafian.
- Who are Enara Bio's investors?
- Enara Bio's investors include RA Capital, SV Health Investors, Pfizer Ventures, Samsara BioCapital, Dementia Discovery Fund, M Ventures, Pfizer Venture Investments.